MedPath

Evaluation of a New Design of Crowns in the Posterior Teeth

Not Applicable
Completed
Conditions
IPS-emmax Crowns
Broken Down Molars
Interventions
Other: IPS.emmax endocrown
Registration Number
NCT02110550
Lead Sponsor
Damascus University
Brief Summary

Background: no randomized controlled trial has tried to compare treatment outcomes between the IPS.emmax endocrowns and the IPS.emmax conventional crowns .

Objective: to investigate the clinical performance of the IPS.emmax endocrowns and the IPS.emmax conventional crowns Design and setting: Parallel-groups randomized controlled trial on patients with one or more intensive damaged molars requiring crowning and being treated at the University of Damascus, Dental School in Damascus, Syria .All molars will be examined at the baseline assessment using a modified US Public Health Service (USPHS) criteria.

Participants: Incoming patients to the Fixed Prosthetic and Endodontic Departments will be examined to find any excessively damaged molars requiring crowning. Forty patients will be recruited according to specific inclusion criteria. Randomization will be performed using computer-generated tables; allocation will be concealed using sequentially numbered opaque and sealed envelopes.The included 40 patients will be analyzed (age range between 20-60 years). They will be randomly distributed into two groups with 20 patients in each group (1:1 allocation ratio).

Intervention: Excessively damaged and endodontically treated molars will be restored with IPS.emmax endocrowns or IPS.emmax crowns supported with composite core.

Main outcome measure: marginal adaptation and anatomic form will be investigated clinically and by apical radiographs at the baseline assessment using the modified (USPHS) at six assessment times during an 18-month observation period.

Assessor blinding will be employed.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Patients between 20 to 60 years old
  • Good oral hygiene
  • Gingival index (GI) equal 0
  • Plaque index (PI) equal 0 or 1
  • Primary acceptation and commitment to the trail

Inclusion criteria of molars:

  • Two remaining axial walls at least.
  • 0.5 mm above the gingival line at least for damaged axial walls.
  • Good endodontic treatment and apical seal
  • First and second upper and lower molars only.
  • Against teeth could be natural or crowned.
Exclusion Criteria
  • Patients with an open bite or cross bite.
  • Bruxism
  • Periodontitis
  • Gingival hyperplasia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
IPS.emmax endocrownIPS.emmax endocrownPatients with excessively undermined and endodontically treated molars will receive the IPS.emmax endocrown as the restoration of choice.
Primary Outcome Measures
NameTimeMethod
Change in Marginal Adaptationat 3 months (T1), 6 months (T2), 9 months (T3), 12 months (T4), 15 months (T5), and 18 months (T6) following application

The presence of marginal adaptation means that the restoration margins cannot be distinguished, the probe cannot find a step between the margins and the surrounding tissue, and no discoloration visible.

Change in the Anatomic Format 3 months (T1), 6 months (T2), 9 months (T3), 12 months (T4), 15 months (T5), and 18 months (T6) following application

The anatomic form is considered satisfactory when the crown has a correct contour with tight proximal contact, no worn facets on restorations and no worn facets on opposing teeth.

Secondary Outcome Measures
NameTimeMethod
Change in the Retention Statusat 3 months (T1), 6 months (T2), 9 months (T3), 12 months (T4), 15 months (T5), and 18 months (T6) following application

Retention loss is considered when the crown becomes loose or mobile.

Trial Locations

Locations (2)

Department of Fixed Prosthodontics, University of Damsacus

🇸🇾

Damascus, Syrian Arab Republic

University of Damascus Dental School

🇸🇾

Damascus, Syrian Arab Republic

© Copyright 2025. All Rights Reserved by MedPath